Reduced-Intensity HCT Based on Donor Availability in Patients With Advanced Myelodysplastic Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
J. Clin. Oncol 2021 Jun 09;[EPub Ahead of Print], R Nakamura, W Saber, MJ Martens, A Ramirez, B Scott, B Oran, E Leifer, R Tamari, A Mishra, RT Maziarz, J McGuirk, P Westervelt, S Vasu, M Patnaik, R Kamble, SJ Forman, MA Sekeres, F Appelbaum, A Mendizabal, B Logan, M Horowitz, C CutlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.